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Current oral squamous cell carcinoma chemotherapies demonstrate off-target toxicity, 
which could be reduced by local delivery. Curcumin acts via many cellular targets to 
give anti-cancer properties; however the bioavailability is hindered by its 
physicochemical characteristics. The incorporation of curcumin into emulgel systems 
could be a promising approach for its solubilization and delivery. The aim of this work 
was to develop emulgel systems containing curcumin for the treatment of oral cancer. 
The emulgels containing curcumin were prepared with poloxamer 407, acrylic acid 
derivatives, oil phase (sesame oil or isopropyl myristate). The more stable system was 
evaluated for mechanical and rheological properties, as well as, the in vitro drug release 
profile, permeation and cytotoxic potential to oral mucosa models. The flow-throw 
system evidenced that the formulations could keep 5 min over porcine oral mucosa. 
Emulgel showed pseudoplastic behavior and a gelation temperature of 33 °C, which 
ensure their higher consistency. In addition, 70% of the incorporated curcumin was 
released within 24 hours in an in vitro drug release study and could permeate porcine 
oral mucosa. Monolayers cultures and tissue-engineered models showed the selectivity 
of the drug and systems for tumor cells. The physicochemical properties, subsequent 
release and permeation of curcumin to selectivity kill cancer cells could be improved by 
the incorporation into emulgel systems. 
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Head and neck cancer (HNC), including cancers of the larynx, salivary glands, 
throat and lips, is the sixth most common malignancy worldwide (Colley et al., 2011; 
Hsu et al., 2014; Narihira et al., 2018). Approximately 90% of HNC are classified as 
squamous cell carcinoma. Oral squamous cell carcinoma  (OSCC), originating in the 
mouth and lips (Chen et al., 2019; Narihira et al., 2018) is the eighth most common type 
of malignancy in developed countries, and the third most common form of cancer in 
developing countries (Shrivastava and Shakya, 2019). Although the oral cavity is easily 
accessible, late detection is common and contributes to a poor 54% 5 year survival rate 
and consequently over half million deaths worldwide each year (Brener et al., 2007; 
Goertzen et al., 2018; Nakagaki et al., 2018). OSCC is linked to a diverse range of risk 
factors including smoking, excessive alcohol consumption, human papillomavirus 
infection, the aging population, immunosuppression and UV radiation (Brener et al., 
2007; Hsu et al., 2014; Narihira et al., 2018) which leads to the transformation of 
healthy oral keratinocytes (predominately in the floor of the mouth and on the lateral 
tongue), to pre-malignant dysplastic lesions and, in 10-20% of lesions, further 
progression to OSCC (Brener et al., 2007; Colley et al., 2011; Ettinger et al., 2019; 
Graciano et al., 2015; Hsu et al., 2010; Longo et al., 2011). Current treatment modalities 
consist of radiation, chemotherapy and surgery yet despite recent advances in chemo- 
and radiotherapy, the prognosis is still poor. Considering that treatment primarily 
happens in the outpatient setting, patients have shown many diverse effects and 
complications, including swallowing difficulties, xerostomia, malnutrition, oral 
mucositis, facial disfigurement that can be severe enough to lead to hospitalization 





diagnosis are urgently needed to improve the prognosis of this deadly disease (Narihira 
et al., 2018). 
Curcumin (CUR), a yellow polyphenol derived from turmeric roots (Curcuma longa 
Linn), is considered as a pleiotropic molecule. Among its diverse biological properties, 
anti-cancer activities have been reported in a wide range of cancer cells including liver, 
pancreatic, cervical, stomach, colon, breast and OSCC (Anand et al., 2008; de Souza 
Ferreira and Bruschi, 2019; Khan et al., 2018). Scientific studies have confirmed that 
CUR cellular effects are via multiple molecular paths including reduction of nuclear 
factor-κB (NF-κB) activated by carcinogens, inflammatory cytokines (interleukine-1 
and tumoral necrosis factor) and extracellular stresses (UV light and smoke) (de 
Campos et al., 2017; Mazzarino et al., 2015; Sharma et al., 2006; Zlotogorski et al., 
2013), increase in the expression and function of cytochrome P450 (CYP) 1A1 and/or 
CYP1B1 (Zlotogorski et al., 2013), increase in the expression of linking proteins of 
growth factor like insulin (IGFBP-5), decrease on the expression of PD-L1 and pSTAT3 
by immunosuppressive pathway (Liao et al., 2018), down-regulates HIF-α 
(heterodimeric transcription factor) remarkably up-regulated in areca quid chewing 
associated-OSCC (Kunnumakkara et al., 2017; Lee et al., 2010), upregulating micro 
RNA-9 expression and inhibiting Wnt/β-catenin  signaling pathway (Xiao et al., 2014). 
These molecular targets are involved in carcinogenesis and CUR acts via decreasing cell 
proliferation, migration and increasing cellular death and apoptosis rate (de Campos et 
al., 2017; Zlotogorski et al., 2013). Despite strong evidence for  the pleiotropic activity 
of CUR in OSCC, the molecular displays challengeable physicochemical properties 
such as high lipophilicity (log P = 3.29) and photosensitivity, that limits the 
bioavailability, therapeutic effects and clinical applicability (Anande et al., 2008; 





drug delivery systems to improve the solubility and photosensitivity issues of CUR to 
enable clinical utilization (Akolade et al., 2018; Karavasili et al., 2019; Katas et al., 
2017; Khan et al., 2018; Rodero et al., 2018). 
Topical delivery of drugs directly to the oral mucosa is considered important in 
many epithelial diseases, including OSCC, to avoid unwanted side effects, systemic 
toxicity, as well as, first-pass metabolism (Bruschi and de Freitas, 2005; Hearnden et 
al., 2009). Moreover, the oral mucosa is an attractive site for the administration of drugs 
as it is less susceptible to damage or irritation with a fast recovery time (5 to 6 days) 
(Russo et al., 2016; Satheesh Madhav et al., 2012). 
The ability to solubilize hydrophilic and hydrophobic molecules such as CUR, and 
also thicken and emulsionate the compounds of formulations are advantageous 
properties of poloxamer 407 (P407). These properties are due to its block structure 
containing hydrophilic regions of polyethylene oxide (PEO) and hydrophobic regions of 
polypropylene oxide (PPO), that assemble into polymeric micelles with temperature 
increase. These polymers help in the structuration of emulgels, which are formed by the 
combination of emulsions and gels. Emulgels enable the higher availability and 
solubilization of hydrophobic drugs, improving the stability and control of the delivery 
(Djekic et al., 2015; Ibrahim et al., 2013; Lopez-Martínez et al., 2015; Rocha et al., 
2013; Shen et al., 2015). These systems are basically composed of aqueous phase, oil 
phase, emulsifying agent and gelling (Ajazuddin et al., 2013; Pant et al., 2015; Sultana 
et al., 2014).  Sesame oil and isopropyl myristate were selected as the oil phase for the 
systems as they have been reported successfully for other emulgel formulations 
(Acharya et al., 2001; Singh et al., 2015; Subramanian et al., 2005). In addition, 
bioadhesive polymers, such as Carbopol 974P® (C974P) and polycarbophil (PC), were 





efficacy; all important in the development of formulations for administration to the oral 
cavity (De Souza Ferreira et al., 2017; Sabrina Barbosa De Souza Ferreira et al., 2017). 
The aim to this study was to develop emulgel systems containing P407, C974P or 
PC, sesame oil or isopropyl myristate and CUR as a treatment for OSCC. We 
investigated the oil phase and bioadhesive polymers for improved physical. The best 
combination of P407, oil phase, bioadhesive polymer and CUR was evaluated for 
mechanical, mucoadhesive, rheological properties. Moreover, the in vitro drug release 
profile, permeation and cytotoxic potential to both OSCC monolayers and three-
dimensional tissue engineering oral mucosa models of the emulgel systems were 
evaluated. 
 
2. Materials and methods 
2.1. Materials 
Curcumin C3 complex® was kindly donated from Sabinsa® (West Windsor, USA). 
Poloxamer 407, mucin from porcine stomach type II, and phosphate buffered saline 
(PBS) were purchased from Sigma Aldrich (St. Louis, MO, USA). Carbopol 974P® and 
polycarbophil were received from Lubrizol (São Paulo, SP, Brazil). Isopropyl myristate 
and polysorbate 80 (Tween 80) were purchased from Synth® (Diadema, SP, Brazil), 
while sesame oil was received from Veris óleos vegetais® (Vinhedo, SP, Brazil). 
Triethanolamine, neutralizing agent, was purchased from Galena (Campinas, SP, 
Brazil). 
  
2.2 Preparation of mucoadhesive formulations 
Formulations were prepared containing 15% (w/w) P407, 0.1% (w/w) CUR and 





dispersed in oil phase (isopropyl myristate or sesame oil) until complete homogeneity 
was achieved. Then, this dispersion was incorporated in P407 and purified water-
polymeric dispersion, previously prepared. Subsequently, a C974P or PCB-dispersion 
was added to the mixture containing P407, oil phase, CUR and purified water, and 
agitated until the complete homogenization of the system. The pH of each formulation 
was adjusted to 7.0 with triethanolamine and the formulations were stored in a fridge 
for, at least, 24 hours before further analysis. 
 
2.3. Preliminary stability studies 
The studies were carried out in cycles of freeze thaw, where the nanostructured 
systems were submitted to -5± 2 °C for 24 hours and 40 ± 2°C for 24 hours, during 12 
days and representing six cycles as described in Cosmetics Stability Guide from 
ANVISA (Brazil) (Agencia Nacional de Vigilância Sanitária, 2004). The systems were 
evaluated regarding the organoleptic characteristics (color, smell and aspect), 
morphological and size properties of oily droplets (mean diameter and polydispersity 
index), centrifugation sedimentation analysis (instability index) and drug content during 
time 0 and cycle 6 (Lima et al., 2008; Morais, 2006). Regarding the centrifugation 
sedimentation index, the samples were placed in a bucket in optical path of 2 mm and 
centrifuged at 4000 RPM for 1 hour in an analytical centrifuge (LUMiSizer, LUM 
GmbH, Berlin, Germany). The samples were exposed to the centrifuge force; an infra-
red light illuminated the bucket allowing the measurement of the transmitted light 
according to time and position in all bucket length simultaneously. The transmittance 
profiles and instability index (Ii) were obtained (Hou et al., 2010; Xu et al., 2017). For 
the morphological analysis, images were taken from an optical microscope (Kozo 





tangents in opposite sides) was calculated from the measurement of approximately 800 
droplets of oil phase for each formulation using Image Pro Plus 4® (Media Cybernetics, 
Inc., Rockville, USA) and droplet size distribution was estimated (Nova et al., 2019; 
Marcela B. Oliveira et al., 2018; Toledo Hijo et al., 2015; Tonon et al., 2011). For drug 
content of CUR in the emulgel, 1 g-formulations was dispersed in 5 ml of methanol, 
transferred to a 25 ml-volumetric flask and sonicated for 15 min in a sonicator water-
bath (Unique ultra-cleaner 1400, Indaiatuba, Brazil). Subsequently, the volumetric flask 
was completed to 25.0 ml with methanol and the mixture was centrifuged at 4000 RPM 
for 5 min (Z36HK Hermle Labortechnik GmbH, Wehingen, Germany). The samples 
were filtered with a PTFE membrane (Sartorius, Goettingen, Germany) with 0.45 µm 
pore size and 20µl-sample was injected into a HPLC Shimadzu LC CBM 20a system 
(Tokyo, Japan) equipped with a manual injector (7725i) and a UV-Vis detector (SPD 20 
A). The stationary phase was a C18 reversed phase column (5 µm X 4.6 mm X 250 
mm) (Luna PFP, Phenomenex®, Torrance, USA) and a solution containing acetonitrile 
and acetic acid (1.5 %, v/v) is the mobile phase in a gradient elution. The peak area was 
detected at 425 nm and the flow was adjusted to 1.0 ml/min.  
 
2.4. Mechanical analysis 
A TA-XTplus Texture Analyzer (Stable Micro Systems, Surrey, England) was used 
for performing the textural profile analysis (TPA) and the measurement of the work 
required to expel the formulations from a syringe (syringeability). 
TPA analysis was performed at 5 °C, 25 °C and 37 °C. 16 g-sample was carefully 
placed to bottles, avoiding the entrapment of air. In TPA mode, the samples were 
compressed two times by an analytical probe (10 mm diameter) at 2 mm/s with 15 s of 





a defined depth (15 mm). The properties (hardness, compressibility, adhesiveness, 
elasticity and cohesiveness) were calculated from force-time and force-distance plots 
(de Francisco et al., 2019; Sabrina Barbosa De Souza Ferreira et al., 2017). At least, 
three replicates were performed for each analysis. 
The work necessary to expel the formulations from a syringe (syringeability or 
resistance to compression of systems inside the syringe) was investigated using a 
texturometer TA-XTplus in compression mode (Jones et al., 1996). In 1ml-plastic 
syringes, the systems were carefully packed until 30 mm avoiding the entrapment of air. 
The determination was carried out at 25 °C, where each syringe was fixed vertically and 
pressed at 2.0 mm.s-1 until reach the initial contact with the syringe plunger with at least 
three replicates (Borghi-Pangoni et al., 2015; Bruschi et al., 2007). A graph of force per 
distance was derived during the compression of the plunger. 
 
2.5. In vitro evaluation of mucoadhesive force 
In tension mode, the mucoadhesive properties of the systems with or without CUR 
were investigated using the same texture analyzer described previously. Initially, the 
compression of crude mucin provided mucin discs, which were hydrated in mucin 
solution 5% (w/w) for 30 s, placed in the bottom of the TPA probe and the excess of 
mucin solution was slightly removed with absorbent paper. Afterwards, a shallow 
container containing the sample was positioned behind the analytical probe, which was 
lowered until the mucin disc and sample were in contact and 0.1 N force was applied for 
30 s to ensure intimate contact between the two surfaces. Then, 1.0 mm/s – speed was 
used to raise the probe and the force necessary to separate the mucin disc and the 







2.6. Ex vivo flow liquid falling mucoadhesive evaluation 
Porcine oral mucosa was taken from the cheek of young, white and freshly 
slaughtered pigs (from a slaughterhouse authorized from human consumption by 
Brazilian Agriculture Ministry). The cheek was gently washed with PBS buffer and the 
oral mucosa was excised with scissors and a surgical scalpel. The samples were stored 
at -18 °C in a PBS solutions and defrosted at room temperature on the experimental day 
after 48 hours of the oral mucosal preparation (Ferreira et al., 2019). These samples 
were used for the determination of mucoadhesive properties, as described by Oliveira 
and collaborators (Oliveira et al., 2018). In a chamber with temperature control (37 °C), 
the samples of oral mucosa were placed on the channel testing behind the syringe-pump 
system, where PBS flowed over the mucosal samples at a flow rate of 4 ml/min. 
Formulation (100 µl) was positioned and warmed over the mucosa to allow the proper 
gelation for 5 min. Subsequently, the buffer flowed over the set during 20 min and 
samples (elution liquid) were collected in 1, 2, 5, 10, 15, 20, with 1% (V/V) Tween 80 
to let the complete solubilization of the drug. Samples were diluted with methanol (1:2) 
and the drug was quantified in the liquid chromatography method, as previously 
described. The retention data was determined by the deduction between the total of 
formulation and the amount of formulation flowed from the surface of the substrate. At 
least three replicates were carried out and fresh mucosa was used for each experimental 
assay (da Silva et al., 2017; Madsen et al., 2013;Oliveira et al., 2018). 
 
2.7. Morphological analysis by scanning electron microscopy 
An electron scanning microscope Quanta FEI (Thermo®, Oregon, USA) was used 





Initially, 2g-system was freeze-dried, the dried material was deposited over a double-
sided tape, coated with colloidal gold under argon atmosphere. Then, micrographs were 
derived from the scanning electron microscopy (SEM). 
  
2.8. Rheometry 
Rheological analysis of systems was investigated at 5 °C, 25 °C and 37 °C ± 0.1 °C 
using a controlled stress rheometer (MARS II, Haake Thermo Fisher Scientific Inc., 
Newington, Germany) with parallel steel cone-plate geometry (35 mm diameter, 
separated by a fixed distance of 0.052 mm) for at least three replicates samples. 
Replicates were carefully positioned and allowed to equilibrate (1 min) before analysis 
to ensure minimal shearing of the sample. The continuous shear flow rheology was 
performed in flow mode, where downward and upward curves were obtained (shear 
rates from 0 to 2000 s-1), increasing over 150s-period, retained at the high limit during 
10 s, and, subsequently decreasing over 150s-time. The software RheoWin 4.10.0000 
(Haake®) allowed the calculation of the hysteresis area. Moreover, Power Law 
(Oswald-de-Waele equation) rheological model was used to determine the flow 
properties (Equation 1) (Bruschi et al., 2007; De Souza Ferreira et al., 2017; Fabri et al., 
2011): 
 
     (1)   
  
Where τ is shear stress (Pa), k is consistency index [(Pa.s)n],  is shear rate (s-1), and n is 
the flow behavior index (dimensionless). 
The yield value was evaluated by the rheological models Casson (Equation 2) and 






    (2) 
 
Where τ is shear stress (Pa), n is flow behavior index (dimensionless), τo is yield value 
(Pa),  is shear rate (s-1), and ηp is Casson plastic viscosity. 
 
τ=τo+K n     (3) 
 
Where τ is shear stress (Pa), τo is yield value (Pa), k is consistency index,  is shear rate 
(s-1) and n is flow behavior index (dimensionless). 
The oscillatory rheology was performed in oscillatory mode. Initially, the linear 
viscoelastic region (LVR) was investigated for each system and the frequency sweep 
assay was carried out from 0.1 to 10.0 Hz at 5 °C, 25 °C and 37 °C. The viscoelastic 
characteristics of the emulgels, storage modulus (G’), loss modulus (G”), dynamic 
viscosity (η’) and the loss modulus (tan δ) were calculated (de Francisco et al., 2019; De 
Souza Ferreira et al., 2017). 
The gelation temperature (Tsol/gel) determination was performed in oscillatory mode 
with temperature ramp. Firstly, the LVR of each formulation was carried out at 5 °C and 
60 °C. Subsequently, the temperature sweep analysis was performed over a range of 5-
60 °C at 1.0 Hz-frequency and 10 °C /min-rate heating with controlled stress. RheoWin 
4.10.0000 (Haake®) allowed the calculation of the viscoelastic properties (G’, G”, η’ 
and tan δ) in each case. Tsol/gel (temperature at which G’ was halfway between solution 
and gel) was calculated for all systems where η’ increased significantly by the rise of 






2.9. In vitro drug release profile investigation 
The release of CUR from the emulgel was performed using double-wall glass 
beakers with temperature control (37 ± 0.5 °C). The emulgel (1.0 g) was positioned on 
the bottom of the recipient at 37 °C to allow complete gelation. Then, the release media 
containing aqueous solution of Tween 80 (1%, V/V) was carefully transferred to the 
vessel and kept under constant agitation to achieve sink condition (Borghi-Pangoni et 
al., 2015; Borghi-Pangoni et al., 2017). Aliquots of samples (500 µl) were collected in 
fixed time intervals (0.5 h, 1 h, 2 h, 3 h, 4 h, 6 h, 8 h and 24 h), replaced by the same 
volume of fresh medium. The aliquots were diluted in methanol (1:2), filtered with 
PTFE membranes and quantified by HPLC method, previously described (Oliveira et 
al., 2018). The plotting of the amount released versus time allowed the calculation of 
release profiles, which were fitted by Korsmeyer-Peppas equation (describes the drug 
release from polymeric matrix systems) (Zhang et al., 2010): 
 
     (4) 
 
Where F means the fraction the drug released, t represent time released, k is the 
incorporation kinetic constant of geometric and structural properties of the apparatus 
and n is the release exponent that tells mechanism of the drug release. 
 
2.10. Ex vivo permeation assays 
The permeation of CUR from emulgel systems was evaluated by Franz cell 
apparatus and photoacoustic spectroscopy (PAS) in porcine oral mucosa (taken from 
porcine cheek as previously described). Using Franz cell apparatus, the receptor media 





maintained at 37 °C with constant stirring. The porcine oral mucosa was positioned 
between the receptor compartment and donor compartment, where 1 ml of formulation 
was homogeneously distributed. Medium (500 µl) was collected at 0.5 h, 1 h, 2 h, 3 h, 4 
h, 6 h, 8 h and 24 h, diluted in methanol (1:2), filtered in PTFE and quantified in HPLC 
method and replaced by fresh medium. At least three replicates were carried out 
(Borghi-Pangoni et al., 2017; Junqueira et al., 2016). In order to quantify the retention 
of CUR in tissue, the porcine mucosa were taken from the recipient, cut in small pieces, 
placed in volumetric flask (5 ml) with methanol, sonicated for 15 min, completed, 
filtered in PTFE membranes and quantified in HPLC method, previously described, in 
at least three replicates. 
For PAS, a set containing 30 µg of system over the surface of 1 cm³ of oral mucosa 
were allowed in contact during 30 min and, then the sample was investigated by 
photoacoustic spectroscopy. The homemade experimental equipment containing 1000 
W Xenon arc lamp (Oriel, model 68820), as source light with 800W- nominal power 
was used for this essay. When passing through 3.16 mm input and output slits of a 
monochromator (Oriel, model 77250), the light was diffracted, and, subsequently, 
modulated at 13 Hz with a mechanical chopper (Stanford Research Systems, model SR 
540) to focuses the sample. The photoacoustic signal obtained by pressure changes 
resulting in period heating of the sample, placed inside the photoacoustic cell and sealed 
with transparent quartz window (thickness of 2 mm and diameter of 8 mm), was 
collected by a capacitive microphone (Brüel and Klaer, model 2669). The influence of 
the depth of tissue which contributed to the photoacoustic signal used the thermal 
diffusion length (µs):  
 






Where D means the sample thermal diffusivity (cm-2s-1) and f represents the light 
modulation frequency (Hz). Considering the similarity between porcine and human oral 
mucosa,  D= 4.1 x 10-4 cm² s-1 (Brown et al., 1993) and f=13 Hz. Consequently, µ s was 
31 µm for oral mucosa. Considering that the photoacoustic signal is proportional to the 
sample coefficient absorption, the photoacoustic signal was interpreted by band 
absorption spectra (Rosencwaig, 1980). All samples were normalized to the carbon 
black- sample to eliminate the source emission intensity in each wavelength (Ames et 
al., 2017). The spectra of at least three porcine oral mucosa was investigated from the 
illuminated side of tissue to be measured and, subsequently, the tissue was upside down 
to illuminate the opposite side (Borghi-Pangoni et al., 2016; Campanholi et al., 2018). 
 
2.11. Cell cultures 
The cell lines, Cal27 (ATCC, Manassas, VA, USA, CRL-2095) isolated from a 
tongue squamous carcinoma (ECACC, Health Protection Agency Culture Collections, 
Salisbury, UK) and FaDu (LGC Promochem, Middlesex, UK), originally isolated from 
a hypopharyngeal tumor were used in this study. Cal27 were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) high glucose, while FaDu cells were cultivated in 
RPMI-1640. Both medium were supplemented with 10% (v/v) fetal calf serum (FCS), 
100 UI/ml penicillin and 100 µg/ml streptomycin and 2 mM L-glutamine. Moreover, 
immortalized cell line FNB6 (a kind gift from Professor Keith Hunter) were originally 
isolated from normal oral keratinocytes. FNB6 were cultures in Green’s medium 
containing DMEM high glucose and Ham’s F12 medium 3:1 (v/v) enriched with 10% 
(V/V) FCS, 2 mM L-glutamine, 0.625 µg/ml amphotericin B, 100 UI/ml penicillin and 





0.18 mM adenine, 5 µg/ml transferrin and 0.2 µM triiodotironine. All cells were 
incubated at 37 °C in a 5% CO2 humidified atmosphere. When 80% confluence was 
reached, the cells were sub-cultivated using trypsin-EDTA. 
 
2.12. Cytotoxicity evaluation of CUR and formulations against buccal cell lines 
The viability of FNB6, Cal27, FaDu cell lines was investigated after 24 hours of 
treatment with CUR and the formulations with or without CUR. Initially, 2 x 105 cells 
were seed in each well of a 96-well plate. After overnight culture, increasing dilutions 
of CUR (previously solubilized in DMSO) or formulations with and without CUR in 
medium were added with final concentration of 2.5, 5, 10, 20, 40, 80, 120 and 240 µM 
and 10, 20, 300, 500, 1000, 1500 and 2000 µM, respectively, for 24 hours along with a 
media only negative control. Subsequently, the media with CUR was aspirated, cells 
were washed with PBS (three times) and 200 µl media added to each well. After a 
further 24 hours of incubation, 0.5 mg/ml MTT (Sigma, Poole Dorset, UK) solution was 
added to the cells, which were incubated for 1 hour at 37 °C. Finally, the solution was 
removed, and acidified isopropanol added to solubilize blue formazan crystals. The 
absorbance was measured in a plate reader at 570 nm, with 620 nm reference correction, 
at least three times for each cell line. 
 
2.13. Tissue-engineered oral mucosal equivalents 
Oral mucosal models were constructed as previously described (Colley et al., 2011; 
Jennings et al., 2016). Initially, freeze-dried rat-tail collagen previously dissolved in 0.1 
M acetic acid to give a final concentration of 5 mg/ml, was mixed with L-glutamine, 
FBS, 10 x DMEM and reconstitution buffer (2.2% sodium bicarbonate, 4.8% HEPES, 





Subsequently, NOF were added to the collagen gel at a concentration of 2.5 x 105 
cells/ml. After gentle homogenization, 1 mL was transferred to 12-well hanging inserts 
(0.4 mm pore; Millipore) and allowed to set in a humidified atmosphere at 37 °C for 2 
hours. The inserts were submerged in DMEM high glucose and incubated for 2 days, 
after which 5 x 105 normal oral keratinocytes (FNB6) or 2.5 x 105 Cal27 was seeded on 
top of each model. FNB6 models were cultured in Green’s medium, while Cal27 
models were cultured in DMEM high glucose supplemented as previously described. 
After a further 2 days, the models were raised to an air-to-liquid interface and cultured 
for 14 days. 
 
2.14. Cytotoxicity using tissue-engineered oral mucosal 
The cytotoxicity of the models was performed as recommended by the OECD 
standards (OECD 439) (OECD, 2015). Briefly, the CUR diluted in media (9 µM, 240 
µM and 380 µM) and emulgel with and without CUR (pure and diluted in PBS, 1:4) 
were applied to the models, which were incubated for 24 h, washed three times with 
PBS and cultured for a further 42 hours in fresh medium. Subsequently, the models 
were washed with PBS and incubated in MTT solution (1 mg/ml) for 3 hours. After 
MTT solution was removed, acidified isopropanol (0.1 M HCl in 2-propanol) was 
added to each model with gentle agitation to remove the formazan crystals. The optical 
density was measured in a spectrophotometer (Tecan, Männdorf, Switzerland). Viability 
was expressed to the viability relative to the negative control (Colley et al., 2018). 
These analyses were performed in triplicate. 
 





In the histological analysis of tissue integrity post treatment, the models were 
removed from the medium, washed with PBS and fixed in 10% formalin overnight. 
Then, the models were subjected to routine histological processing and finally paraffin 
wax embedded. Using a Leica RM2235 microtome (Leica microsystems), sections (5 
µM) were cut and stained with hematoxylin and eosin (Colley et al., 2018). 
 
2.16. Statistical analysis 
The CUR presence and temperature effect in consistency index, flow index, yield 
value, hysteresis area and textural parameters (hardness, compressibility, adhesiveness, 
elasticity and cohesiveness) were statistically compared using two-way variance 
analysis (ANOVA). In addition, one-way ANOVA was used to investigate the effect of 
CUR presence in vitro mucoadhesion and syringe-ability. Moreover, t-test student 
determined if the dynamic viscosity of formulations increased with temperature 
increase. Moreover, the effect of drug, formulation and time exposition was evaluated 
by two-way ANOVA. Tukey post-hoc test was used to compare individual groups of all 
cases of ANOVA. 
 
3. Results and discussion 
3.1. Preliminary stability studies  
The preliminary stability studies, mainly by freeze-thaw cycles, displayed 
fundamental importance in the development of oil-water-based systems (Chhibber et al., 
2019; Xu et al., 2016), including emulgels. These systems have shown great importance 
to solubilize hydrophobic drugs such as CUR in the hydrophobic core of P407 with the 
oil phase and the hydrophilic shell that would interact with mucoadhesive polymers 





this study were sesame oil (SO) from Sesamum indicum L., and isopropyl myristate 
(IM) (Acharya et al., 2001; Pant et al., 2015; Singh et al., 2015; Subramanian et al., 
2005; Sultana et al., 2014).  C974P and PC have different cross-linking rates, which 
impacts directly on the viscosity of solutions containing these polymers (De Souza 
Ferreira et al., 2017; De Souza Ferreira et al., 2017). In order to find the emulgels that 
would display the best interaction and absence of phase separation, the systems 
containing P407 and CUR had their physical stability tested in two different types of oil 
phase (OS and IM) and mucoadhesive polymers (C974P and PC) (Table 1).  
During the development of new pharmaceutical buccal dosage forms, the choice of 
dose for local administration is very important (Hao and Heng, 2003). Considering that 
these systems aim the application in oral squamous-cell carcinoma, the drug content 
should be in the therapeutic levels not leading to toxic effects to normal cells and, at the 
same time, presenting effects in cancer cells. Previous studies in oral cells (Jelezova et 
al., 2015; Kim et al., 2012; Mazzarino et al., 2015) have demonstrated the CUR 
concentrations which show cytotoxic effects and lead to cellular apoptosis are around 40 
and 100 µM. Cheng and collaborators (Cheng et al., 2001) performed phase I clinical 
studies in humans and found the absence of toxic effects, after the oral administration of 
up to 8000 mg CUR per day. Besides the therapeutic effects, it is important to use a 
CUR concentration which P407 can carry. Studies have demonstrated that P407 shows 
high carry capacity of CUR by partitioning inside the hydrophobic core by the self-
assembly of triblock polymer with a temperature increase (Sahu et al., 2011). 
Considering the concentrations which present toxic effect versus oral squamous cells 
and the necessity to use an excess of CUR due to release and permeation processes, the 





desirable amount of formulation in each dose, considering the defined therapeutic 
regimen. 
The formulations (Table 1) were exposed to thermal stress and gravity acceleration 
to investigate their stability and changes in the physico-chemical properties. Figure S1 
(Supplementary data) shows the formulations before (after 24 hours at 40°C) and after 
the end of the freeze-thaw cycles (after 24 hours at -5 °C). I it was possible to verify that 
the formulations F2, F3 and F4 showed a brownish coloring with CUR precipitate after 
the end of the freeze-thaw cycles (Figure S1B, supplementary data). Formulation F1 
displayed a yellowish color with the absence of CUR precipitates. This suggests that the 
interaction between P407, C974P and SO provided better incorporation of CUR in the 
hydrophobic P407-core which hindered the formation of CUR-precipitates. Moreover, 
C974P and SO display higher viscosity than PC and IM, which provides a stronger 
structuration.  
Formulations had their stability evaluated in the analytical dispersion analyzer 
(LUMsizer®) at time 0 (Caddeo et al., 2013). The graphs of the position of the 
formulations inside the bucket (mm) versus the transmittance profile during the 
analyzed period showed (Figure S1A, supplementary data) slight changes in 
transmittance profiles for the formulations containing IM were observed. Alterations in 
a transmittance profile mean a physical destabilization of the formulation, whereas an 
overlapping profile means that these formulations are stable with gravity acceleration. 
Moreover, this equipment provides the instability index (Ii) for each formulation 
ranging from 0 to 1. The instability index equal to 1 means an unstable system, while Ii 
equal to 0 means a stable system. The results reveal that the emulgels containing SO (F1 
and F3) displayed the lowest instability index values, while, systems containing IM (F2 





structural characteristics of oil phases, SO is composed of a mixture of fatty acids 
including mainly oleic acid and linoleic acid, with one or two insaturations of carbonic 
chains composed of eighteen carbons. On the other hand, IM is a synthetic compound 
composed of propano-2-ol and fatty acids including myristic acid with fourteen carbon 
chains, providing lower hydrophobicity, density and viscosity (Rowe et al., 2009). 
Moreover, F1 and F3 differ by the presence of a mucoadhesive polymer, as F1 also 
contains C974P. This carbomer creates higher cross-linking, which renders a higher 
viscosity and better structuration to the preparations, as previously reported (De Souza 
Ferreira et al., 2017). A lower instability index was found for systems containing C974P 
and SO, which confirms the result reported for the freeze-thaw cycle experiments.  
 
[Insert Table 1] 
 
In order to evaluate possible alterations in the morphology and mean diameter of 
oily droplets of the preparations optical microscopy was employed during the initial 
phase and after the 6th cycle. All preparations displayed similar morphologies with 
rounded and dispersed droplets, as shown in Figure S1C (supplementary data). 
The mean diameter of oily droplets and polydispersity index of oily droplets of the 
preparations are displayed in Table 1. Systems composed of SO demonstrated the 
highest polydispersity index at time 0 due to its composition of a mixture of fatty acids 
(Rowe et al., 2009). This characteristic is not desirable since it represents low 
uniformity in droplet size (Nova et al., 2019; Oliveira et al., 2018). At the end of these 
studies, the values decreased, which represents higher homogeneity of the droplet size.  
The type of bioadhesive polymer incorporated influenced the mean diameter of oily 





lower mean diameter of oily droplets in comparison to PC. The higher cross-linking in 
C974P, which has been reported to provide higher viscosity (De Souza Ferreira et al., 
2017), probably hinder the coalescence of oil phase droplets and probably a better 
incorporation of CUR. Comparing the mean diameter of oily droplets at the beginning 
and end of the preliminary stability studies, F1 displayed the lower mean diameter of 
oily droplets that is a favorable characteristic, as well as, better stabilization. The 
determination of mean diameter of oily droplets and polydispersity index was only 
performed for F1, due to the absence of CUR-precipitates.  
The CUR content in the emulgels was determined at the beginning and end of the 
preliminary stability studies (Table 1). All preparations displayed CUR content close to 
the theoretical value (0.1%), at time 0 and without significant statistical differences (p > 
0.05). After thermal stress, F1 displayed similar drug content (p > 0.05). 
The emulgel F1 showed favorable characteristics, including the absence of CUR-
precipitates and lower instability indexes after the centrifugation sedimentation analysis. 
Furthermore, a decrease in the mean diameter of oily droplets and a good polydispersity 
index made F1 the best preparation for further characterization. 
 
3.2. Mechanical characterization 
TPA constitutes an important investigation, since the systems can display resistance 
to saliva (Baloglu et al., 2011; Carvalho et al., 2013) and the results are displayed in 
Fig. 1.  
 






Hardness and compressibility represent the force necessary to remove the 
formulation from the packaging material, its spreadability over the mucosa (uniform 
layer), avoiding the discomfort to the patient and the applications of the emulgel in the 
buccal cavity, respectively. Adhesiveness is a desirable parameter for such systems 
aimed at the wet environment of the oral mucosa expresses the work required to 
overcome the polycarbonate probe surface (Baloglu et al., 2011; Tuǧcu-Demiröz et al., 
2013). The presence of CUR in the formulations decreased the compressibility 
significantly (p < 0.05), which represents a promising finding to facilitate the 
administration of the emulgels over the oral mucosa. The presence of CUR did not show 
a significant influence on the other parameters (hardness, adhesiveness, elasticity and 
cohesiveness). Hardness, compressibility and adhesiveness were all significantly 
increased (p < 0.05) by the increase in temperature, due to the thermoresponsiveness of 
P407. At low temperatures, these system tend to be less viscous in a monomeric state 
and the increase in temperature promotes the dehydration of PPO- chains in the core and 
establishment of micelles where the oil phase is entrapped with CUR, increasing the 
viscosity (Alexandridis et al., 1994; De Souza Ferreira et al., 2015). 
Elasticity and cohesiveness are properties related to the semi-solid ability to flow 
and return to its initial state and restructuration and molecular interactions after 
subsequent shear stresses, respectively (De Souza Ferreira et al., 2015; Pereira et al., 
2013; Tuǧcu-Demiröz et al., 2013). Both these parameters were not affected by either 
the incorporation of CUR or increase of temperature. Moreover, the adhesiveness, 
preliminary evidence of adhesion, did not show a significant increase, which is possibly 
due to the lower specificity interaction evaluated by the adhesion between formulation 





In order to simulate the administration of the systems over the oral mucosa, the 
work required to expel the emulgel from a syringe was also evaluated. The 
syringeability of CUR-emulgel (47.5910 ± 1.0517 N.mm) was slightly lower than 
emulgel without CUR (49.9990 ± 2.3954 N.mm); however the effect of the 
incorporation of CUR was not significant (p > 0.05).  
 
3.3. Mucoadhesive properties 
A mucin disc partially hydrated was employed to determine the mucoadhesive 
properties by detachment force between the two surfaces (mucin disc and formulation) 
over time (Andrews et al., 2005; da Silva et al., 2017). The mucoadhesion strengths of 
the formulations with and without CUR were 0.1859 ±0.0086 N and 0.1644 ±0.0120 N, 
respectively. CUR presence significantly increased (p = 0.000921) the mucoadhesive 
force of the formulations.  
The mucoadhesive properties of systems were also evaluated by the falling liquid 
method, which evaluates the ability of a system to maintain adhered to the surface of 
oral mucosa with falling liquid (PBS) dropped over the sample at 4 ml/min for 20 
minutes (da Silva et al., 2017; Madsen et al., 2013; Oliveira et al., 2018). Despite the 
wide variability in the salivary flow rate in physiological conditions, this flow rate was 
chosen to investigate how the formulation would behave in harsh conditions simulating 
stimulated salivary flow (Humphrey and Williamson, 2001; Iorgulescu, 2009; Navazesh 
and Kumar, 2008).  The detection of the amount of gel adhered is calculated indirectly 
by determining the amount of CUR eluted with buffer from the beaker by HPLC. This 
analysis was performed for just the CUR-emulgel as shown in Fig. 2. There was a 
significant decrease (p < 0.05) in the cumulative retention of the emulgel for all time 





mucosa decreases significantly. After 10 and 20 min, the emulgel was completely 
removed from the oral mucosa and it was observed the presence of formulation only 
until 5 min. 
 
[Insert Figure 2] 
 
 
3.4. Morphological analysis by SEM 
The morphological properties of the possible network formed by the emulgel with 
and without CUR were investigated by SEM (Fig. 3). Fragments and heterogeneous 
structures were observed in the micrographs of the emulgel, between a well-defined 
polymeric network without the presence of diverse channels commonly found in the 
micrographs of gels (Campanholi et al., 2018). Moreover, it was possible to observe 
some sparse holes were probably the oil phase would be located and rough surface in an 
oriented direction. Conversely, the formulations containing CUR (Fig. 3C and 3D) 
displayed a smoother surface with less holes and some possible droplets of oil phase 
sparsely distributed.  
 
[Insert Fig. 3] 
 
3.5. Rheological characterization 
The continuous shear rheology of emulgels in the presence and absence of CUR 
were investigated at 5 °C, 25 °C and 37 °C (Figure S2, supplementary data). All 
formulations displayed non-Newtonian behavior. The increase in temperature increased 





mainly at 5 and 25 °C, due to the thermoresponsive polymer, P407 (De Souza Ferreira 
et al., 2015; Dumortier et al., 2006). The emulgels with and in the absence of CUR 
showed similar rheological characteristics at 5 °C, because of the P407 conformation.  
 Both formulations were investigated until 1000 s-1 at 37 °C, but the preparations 
containing CUR showed higher thixotropy area. This is considered a favorable property 
for emulgels which has been reported to promote higher stability to the systems and 
bioavailability of the drug (Ajazuddin et al., 2013).  
The consistency index (k) and flow behavior index (n) were calculated by Ostwald 
de Waele equation (power law), which are expressed in Table 2. The effects of 
temperature increase and CUR presence were statistically evaluated by k and n ( 
Bruschi et al., 2007; De Souza Ferreira et al., 2017; Jones et al., 2009). 
There was a significant increase (p < 0.05) of consistency index (K) and significant 
decrease (p < 0.05) flow behavior index (n) due to the increase of temperature to 37 °C 
and incorporation of CUR. The structural organization of P407 containing SO and CUR 
in the hydrophobic core and the hydrophilic shell interacting with C974P, enabled the 
formation of viscous systems (Dumortier et al., 2006). During the analyses, the oil 
droplets got probably aligned in the shear direction, as previously demonstrated in the 
scanning electron microscopy of other emulgel systems (Santos et al., 2019), with the 
CUR incorporation the droplets movement was probably hampered due to the CUR 
interactions with PPO-portions and SO-fatty acids, increasing the system viscosity. The 
n values were lower than 1, demonstrating a non-Newtonian characteristic, which is 
typical of semisolid systems (Hemphill et al., 1993).  
 






It was found a significant increase (p < 0.05) of the hysteresis area due to the 
incorporation of CUR in the emulgels. Hence, there is an improvement of the thixotropy 
indicating the higher malleability during the preparation of these systems with the 
application of high shear rates including agitation and pumping, as well as, during the 
application of the emulgels in the buccal cavity (De Souza Ferreira et al., 2015).  
The viscoelastic properties of the preparations (Figure S3, supplementary data) 
were dependent of the oscillatory frequency, temperature, and CUR presence. 
Formulations showed higher G’ and G” values at 37°C and at the highest oscillatory 
frequencies, due to the structuration of P407. The preparations containing CUR 
displayed increase G’ and G” when compared to preparations without CUR, mainly at 
37°C. 
The η’ of preparations decreased due to the increase of the oscillatory frequency. 
On the other hand, the η’ increased as the temperature increase and in the CUR 
presence. All preparations displayed viscoelastic behavior (tan δ < 1), which is typical 
and desirable for pharmaceutical semisolid preparations, with consequent, higher 
retention in the buccal cavity and higher drug delivery control (Andrews et al., 2005; 
Baloglu et al., 2011; De Souza Ferreira et al., 2015; Jones et al., 2009). In general, the 
CUR presence did not change the viscoelastic properties of preparation (p > 0.05), 
indicating the oscillatory characteristics are due to the secondary interactions between 
P407, C974P and SO. 
The influence of CUR on Tsol/gel of the system was also determined. The drug 
presence significantly decreased the gelation temperature (p < 0.05). CUR-emulgel (F1) 
displayed Tsol/gel of 33.2750 ± 0.0614 °C, while the emulgel without CUR displayed 
35.6230 ± 0.0462 °C. These values were found in the acceptable temperature range 





Therefore, these preparations have shown favorable characteristics for administration in 
the oral cavity, without the risk of seepage and loss at the application site (Bruschi et al., 
2007). 
 
3.6. In vitro drug release profile 
In order to simulate the behavior of the formulation inside the buccal cavity, in 
vitro release profiles of CUR from emulgel were performed (Fig. 4). The release media 
was Tween 80 (1%, w/v) to enable the solubilization of CUR, due to its hydrophobic 
characteristic ( Borghi-Pangoni et al., 2017; de Souza Ferreira and Bruschi, 2019). 
 
[Insert Figure 4] 
 
The in vitro drug release of CUR from the emulgels was slow; after 8 hours only 
30% of drug was released. At the end of the test (24 hours), the formulations had 
released around 70% CUR, which was considered satisfactory for buccal application. In 
addition, it was possible to observe the presence of the formulation after 24 hours, 
which provides a prediction of the unstimulated salivary flow. Even though the ex vivo 
falling liquid test demonstrated that the formulation was washed away in 10 minutes (4 
mL/min flow rate). Therefore, it is not possible to ensure if the formulation would keep 
in the application during 24 hours for CUR release. Future investigations using more 
biorelevant conditions are necessary. The formulations showed first order profile, due to 
its composition (Korsmeyer et al., 1983), the preparations had their mechanism release 
evaluated regarding the general equation (equation 4). The in vitro release profile of 
CUR was fitted by Korsmeyer-Peppas (Power Law) and the release exponent value (n) 





diffusion model, but also, intermediate between 0.5 and 1.0, well known as anomalous 
transport. Considering the rheological and texture characteristics of this preparation and 
the high viscosity, as well as the presence of oil phase, the CUR release mechanism was 
mainly related by diffusion and, the relaxation of the polymer chains. The high speed of 
solvent diffusion to inside the matrix and the low velocity of polymer chains relaxing 
induced the formation of a solvent penetration gradient. The concentration of solvent 
decreases exponentially from the totally swollen region to the center of the matrix 
(Bruschi, 2015). 
 
3.7. Ex vivo permeation assays 
Permeation assay using Franz cell enable the measurement of the CUR amount in 
the receptor medium, the drug retained in the mucosa and the permeation kinetic profile 
may be determined. The slow permeation of the drug through the mucosa without 
reaching the systemic circulation is desirable for the CUR emulgels which are aimed at 
local application (Junqueira et al., 2016). The drug did not reach the receptor 
compartment and 55.0885 ±12.1636 µg/cm³ (6.5467 ± 0.1187 %) of CUR was retained 
in the porcine oral mucosa, which represents an advantageous characteristic, as 
previously discussed. 
The investigation of the optical spectral absorption by a photoacoustic signal 
created by the interaction of matter with radiation of known wavelength is known as the 
basis of photoacoustic spectroscopy (PAS). This is a qualitative method, as it 
determines if the drug can permeate or not and the depth of tissue permeated. Porcine 
oral mucosa was used to evaluate the permeation ability of CUR from emulgels by PAS 






[Insert Figure 5] 
 
The spectra of optical absorption of CUR and the emulgel systems with and without 
CUR (Fig. 5A) were performed to allow visualization of the constituents’ bands by the 
decomposition of the spectra. Thus, an intense band from 300 to 700 nm, with centers 
around 315, 427, 515 and 659 nm could be observed. The main absorption band is 427 
nm, due to ether and the aromatic rings of hydroxyl (Crivello and Bulut, 2005). The 
emulgel 15/0.50/0.75 showed a large band between 300 and 350 nm, whereas CUR 
emulgel 15/0.50/0.75/0.10 displayed from 300 to 500 nm.  
In the optical spectra of mucosa (Fig. 5B), it was possible to observe that all 
samples exhibited a band at 415 nm, that belong to blood vessel. Moreover, a band that 
varies from 500 to 615 nm could be observed in all samples. Additionally, the area of 
permeation behavior at 427 nm (Fig. 5C) demonstrates that free CUR permeated more 
intensely than CUR incorporated in the emulgel. This finding is explained by the release 
and permeation through the mucosal layers for CUR-emulgel. CUR could permeate the 
whole mucosa (818 µm) since the thermal diffusivity wavelength (µ s) was 31 µm for 
both sides of the tissue. 
 
3.8. Cytotoxicity of monolayers cell cultures 
Despite the oral cavity being considered an excellent route for drug delivery 
systems, local tolerance to the oral mucosa and in vitro activity are fundamental aspects 
that should be investigated in the development of drug delivery systems for OSCC 
applications containing CUR. This is especially true for formulations with 
mucoadhesive properties (Kulkarni et al., 2016; Teubl et al., 2013; Zeng et al., 2015). 





mitochondrial activity. Viable cells are able to convert tetrazolium salt to insoluble 
purple formazan by mitochondrial succinic dehydrogenase activity (Fotakis and 
Timbrell, 2006; Zeng et al., 2015). The toxicity test after 24 hours of treatment with 
CUR and formulations with and without CUR against cancerous cell lines, Cal27 and 
FaDu and healthy cell line including FNB6 were performed to evaluate the selectivity of 
CUR activity by cancerous cell lines. This incubation period was used since during the 
in vitro release investigation 70% CUR could be released and the formulation was 
retained after 24 hours, predicting the unstimulated salivary flow. The application of the 
formulation in the oral cavity is subjected to the removal physiological mechanisms by 
salivary flow, speech and swallowing (Bruschi and de Freitas, 2005). 
Cal27 were the most susceptible cell line to free CUR and formulations with and 
without CUR. Although FNB6 are considered as normal, they were more susceptible to 
free CUR than FaDu cells. This is explained by their basal origin; hence, they do not 
represent the mature cells from the superior layer of oral epithelia but represent cells 
from just the basal layer which are actively dividing (Jennings et al., 2016). As a 
consequence, it is necessary to perform cytotoxicity tests in tissue-engineered models, 
which confirm the toxicity of the preparations. Comparative graphs and IC50 values are 
displayed in Fig. 6. 
The viability of Cal27 was significantly decreased (p < 0.05) when treated with the 
formulation with and without CUR. This can be explained by the surfactant properties 
of P407, which could influence the test. 
Despite FaDu cells displayed smaller changes in the viability compared to Cal27, 
the IC50 values were lower when compared to healthy immortalized FNB6 cell lines and 
the effect of CUR in the formulations influenced in the viability of the preparations. 





were treated with CUR emulgel in comparison to free CUR, which is can be explained 
by the release and permeation processes. In addition, the presence of free water in RPMI 
media is enough to solubilize CUR and facilitate its biological activity. Furthermore, the 
incorporation of the drug in the emulgel systems caused the IC50 values to significantly 
decrease (p < 0.05). 
It was observed that for the FNB6 cell line, incorporation of the drug in the 
formulations increased the cellular viability due to the activity of free water, since 
Green’s medium is a rich media supplemented with a number of organic molecules and 
growth factors essential for the maintenance and proliferation of these cell lines 
(Jennings et al., 2016). Furthermore, the formulations without CUR showed IC50 values 
significantly lower than emulgel systems containing CUR (Fig. 6).  
 
[Insert Figure 6] 
 
Cal 27 again had the lowest IC50 which suggests that the composition did not 
influence the susceptibility of this cell line to the drug.  However, the IC50 value could 
be influenced by the concentration of P407 which can be found in the monomeric 
conformation and, interfere with the viability of these cells. 
 
3.9. Evaluation of cytotoxicity using tissue-engineering oral mucosa models 
The use of  relevant three-dimensional models are considered as a more 
physiologically method for the in vitro evaluation of cytotoxicity, since monolayer 
cultures does not reproduce the complexity of the microenvironment and a number of 
reports have demonstrated that they do not properly simulate the cellular toxicity of 





involve the culture of keratinocytes at an air to liquid interface on top of a fibroblast 
populated collagen type I matrix. The models simulate the interactions between 
mesenchyme and epithelium, which is essential for the development and maintenance of 
a normal epithelium. Furthermore, these interactions influence diverse processes 
including the keratinocytes proliferation, migration, differentiation and formation of 
basal membrane in the epithelial-dermis junction by the synthesis of extracellular matrix 
components (Colley et al., 2011). 
In order to evaluate the cytotoxicity of CUR, three-dimensional models of oral 
mucosa were generated using tissue-engineering, in order to simulate normal oral 
mucosa using FNB6 (immortalized keratinocytes) (Jennings et al., 2016) and tongue 
squamous carcinoma (Cal 27) (Colley et al., 2011). Despite, the cell line most 
commonly used to simulate normal oral mucosa is TR-146 (metastatic buccal 
carcinoma), they are not considered appropriate due to the lack of fully differentiation 
and, thus, they cannot accurately represent normal epithelium (Jacobsen et al., 1995; 
Said, 2018). Other alternative to TR-146 would be the use of keratinocytes from 
primary cells, but their short lifespan and donor to donor variability limits their use. 
Thus, the use of immortalized cells which over express telomerase reverse transcriptase-
2 (TERT-2) for unlimited proliferation, are considered a suitable cell source for 
generation of the models (Jennings et al., 2016). 
When comparing the IC50 values of Cal27 and FaDu, Cal 27 showed a much lower 
IC50 due to its susceptibility for both free drug and formulations. Thus, FaDu models 
were not prepared because of its higher IC50, as well as, its complexity, hence, a much 
higher CUR concentration would be required to kill the models and consequently, much 





The use of tissue-engineering oral mucosa for cytotoxicity permits the investigation 
of drug delivery systems for intra-epithelial activity and presents pre-clinical toxicity 
testing before in vivo trials (Moharamzadeh et al., 2017). Cytotoxicity assays were 
performed following the OECD guide (OECD, 2015), which describes the cytotoxicity 
tests in skin and mucosal equivalent models. Three curcumin concentrations were tested 
9 µM, 240 µM and 380 µM, which represents the IC50 in monolayer cultures, maximum 
concentration tested in monolayer and the maximum concentration able to display 
activity without being influenced by DMSO, respectively. The percentage viability was 
calculated by normalizing to a negative control (DMSO concentration equivalent to the 
higher drug tested diluted in medium) (Fig. 7).  
 
[Insert Figure 7] 
 
Tissue-engineered normal oral mucosa (FNB6) was not significantly affected (p < 
0.05) by the increase of CUR concentration with a relative viability approximately 90%. 
Considering the OECD recommendation which compounds are considered as safe when 
the relative viability is higher than 50%, the CUR was considered safe for normal oral 
mucosa until above 380 µM. In higher CUR concentrations, the relative viability would 
be influenced by the DMSO concentration. On the other hand, the relative viability of 
tissue-engineered cancerous oral mucosa model (Cal 27) displayed a significantly 
decrease (p < 0.05) in the relative viability (%), with the higher concentration displaying 
a relative viability lower than 50%.  
Histological analysis was performed on tissue-engineered oral mucosa for normal 
mucosa (FNB6) and tongue squamous cell carcinoma (Cal 27) to evaluate the basic 





models treated with 380 µM CUR. Three layers were observed: epithelium, basement 
membrane and fibroblast-populated connective tissue. 
These results allow the elucidation of activity mechanism and explain the reason of 
different relative viability between the models, which is probably related to the anti-
proliferative activity. Since, the tissue-engineered of normal oral mucosa have 
keratinocytes with high proliferative capacity in the basal layer of epithelia, which are 
able to differentiate and stratify (Colley et al., 2011; Hearnden et al., 2009). On the 
other hand, the tongue squamous carcinoma oral mucosa model presents tumor cells 
with high proliferative capacity, which could have their growth inhibited by CUR. The 
relative viability differences between Cal27 and FNB6 were not observed in monolayer 
cultures, as both Cal27 and FNB6 have high proliferative capacity in 2D. Thus, the 3D 
models represent more physiological characteristics of mucosa and are able to show 
more accurate results to reflect exposure to the 3D oral mucosa. Moreover, the anti-
proliferative activity of CUR could be confirmed by the immunohistochemistry analysis 
(Figure S8, supplementary data). 
The evaluation of cytotoxicity of emulgel systems was performed using the 
formulations without dilution, since the medium is placed underneath the inserts with 
the models (basolateral compartment) and the cells would not die due to being 
smothered (common issue in monolayer cultures), and also diluted in PBS to simulate 
the probable dilution of the systems when there is contact with the salivary flow. The 
same concentrations were tested for emulgel in the absence of CUR; the negative 
control was PBS buffer. The cytotoxicity graph and the relative viability for FNB6 and 
Cal 27 are shown in Fig. 7. 
Thus, the tissue-engineered normal oral mucosa (FNB6) displayed relative viability 





Thus, they are considered as safe, due to absence of strong influence in the viability of 
normal oral mucosa at an air-liquid interface.  
Regarding Cal27, the viability was unchanged by incubation with preparations 
without CUR; around 80%. On the other hand, preparations containing CUR displayed 
a dose-response activity and the relative viability was 50% for CUR emulgel and 80% 
for emulgel diluted in PBS (1:4).  
When comparing the cytotoxicity results of formulations incubated with monolayer 
cultures and tissue-engineered models, it is evident that the complexity of the models 
reduces the efficacy of the formulation with and without CUR. It has been reported in 
literature (Moharamzadeh et al., 2012; Sun et al., 2006) that when experiments are 
moved from monolayer cultures to three-dimensional cultures, a cytoprotective effect is 
observed with higher IC50 for tissue-engineered models.  Furthermore, cytokines and 
growth factors released in 3D models presented in both non-viable and viable cells are 
different of those from monolayer culture (Xu et al., 2009). Moreover, some authors 
(Moharamzadeh et al., 2012) have carried out experiments comparing the response of 
freshly excised human oral mucosa and 3D tissue-engineered mucosa to ethanol and 
sodium lauryl sulfate and observed similar responses.  
 
4. Conclusion 
Emulgel systems containing CUR were developed for oral squamous cell carcinoma 
treatment. The systems preliminary stability, mechanical, mucoadhesive, rheological 
properties were investigated, as well as, in vitro drug release, ex vivo permeation, 
retention characteristics determined. Moreover, biological studies were performed in 
order to investigate the influence of CUR free or when incorporated in the formulations 





engineered models. Preliminary stability studies evidenced that the emulgels containing 
SO and C974P could display lower instability index, smaller mean diameter of oily 
droplets, providing higher stability. Mechanical, softness and syringe-ability parameters 
were not influenced by the incorporation of CUR in the emulgel systems. CUR-emulgel 
remained adhered to the porcine oral mucosa for 5 min. Besides, the incorporation of 
CUR in the emulgel systems did not interfere with the flow and oscillatory rheology but 
a decrease in the gelation temperature which ensure the ability to not move. Despite, 
70% CUR being released in the in vitro release profile assays, the drug could not 
permeate the porcine oral mucosa and was retained in the oral mucosa. Biological 
assays evidenced that CUR affected Cal 27 and FNB6 monolayer viability. When the 
drug was incorporated in the formulations the IC50 for Cal 27 cells decreased, whereas 
the IC50 of FNB6 cells increased. Moreover, the tissue-engineered models have shown 
to be much more realistic tool in the cytotoxicity evaluation of these formulations, once 
the drug and formulations had a relative viability higher in FNB6 models than Cal27 
models, demonstrating the selectivity of the drug and formulations for cancer models. 
Thus, these nanostructured emulgel systems demonstrated interesting results and 
selectivity to cancer cells in tissue-engineered models; which have been shown to 
simulate the human oral mucosa more closely.  
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Fig. 1. Textural properties evaluated at 5, 25 and 37 °C for emulgels containing P407, 
C974P, SO and/or CUR: (A) Hardness, (B) Compressibility, (C) Adhesiveness, (D) 
Elasticity, (E) Cohesiveness. At least, three replicates were evaluated for each value.  
 
Fig. 2.  (A) Cumulative retention profile of emulgel containing P407, C974P, SO and 
CUR retention on porcine oral mucosa over time. Each dot represents the average (± 
standard deviation), of at least, three replicates. (B) Porcine oral mucosa after the falling 
liquid test (20 min). 
 
Fig. 3. Scanning electron micrographs of emulgels containing 15% (w/w) P407, 0.50% 
(w/w) C974P, 0.75% SO, without CUR original magnification x1500 (A) and x 5000 
(B) and containing CUR original magnification x1200 (C) and x4600 (D). 
 
Fig. 4. Curcumin (CUR) release profile from emulgel systems containing 15% (w/w) 
P407, 0.50% (w/w) C974P, 0.75% (w/w) SO and 0.1% (w/w) CUR. 
 
Fig. 5. Optical absorption spectra from PAS: (A) CUR and emulgel system with and 
without CUR, (B) permeation of CUR through the mucosa, (C) permeation behavior 
area of absorption band in 427 nm in porcine oral mucosa.  
 
Fig. 6. Cytotoxicity of formulations: (A) cell survival curves of drug and emulgel, (B) 





oral (FNB6) cell line. Each IC50 value and percent cell survival represent average ± 
SEM (n=3).  
 
Fig. 7. Relative percentage viability (%) and representative images of (A) FNB6 oral 
mucosa  and (B) cancerous oral mucosa (Cal27) treated with negative control and CUR 
in the concentrations 9, 240 and 380 µM (C) FNB6 oral mucosa and (D) Cal27 oral 
mucosa after the incubation with emulgel and CUR emulgel with and without CUR 
without dilution and diluted 1:4. The positive control represents the models treated with 
5% sodium dodecyl sulfate and negative control represents models treated with PBS 
buffer and the higher concentration of DMSO used to dissolve CUR. Scale bar= 300 
µm. 
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